The heterogeneity of circulating lung tumor cells from non-small cell lung cancer patients von Kong, S.L, Tan, S.J, Lim, T.K.H, Poh, H.M, Yeo, T.Z.X, Liu, X, Chua, Y.W, Bhagat, A.A, Lim, W.T, Hillmer, A.M

Volltext

Evolutionary trajectory of Asian EGFR mutation positive lung adenocarcinomas leads to “high intratumor heterogeneity” von Nahar, R, Zhai, W, Zhang, T, Takano, A, Khng, A.J, Lee, Y.Y, Liu, X, Lim, C.H, Lim, T.K.H, Koh, T.P.T, Aung, Z.W, Teo, A.S.M, Chan, C.X, Toh, C.K, Lim, W.T, Lim, B, Tam, W.L, Tan, E.H, Tan, D.S.W, Hillmer, A.M

Volltext

655P De novo MET amplification in EGFR-mutant non-small cell lung cancer von Lee, D.D.W., Wang, L., Lai, G., Lim, T.K.H., Tan, D.S.W.

Volltext

P1.12A.03 Outcome and Transcriptomic Features of Dual EGFR and MET Blockade in NSCLC von Lee, D.D.-W., Ng, W.P., Ang, S.F., Lau, D.P., Wang, L.Y., Lai, G.G.Y., Boey, M.Y.W., Lim, T.K.H., Tan, D.S.W.

Volltext

422P Claudin-1 (CLDN1) expression in nasopharyngeal carcinoma (NPC): Association with immune exclusion and implications for immune checkpoint inhibitor (ICI) therapy von Yeo, E.L.L., Neo, J., Ong, E., Chow, W.M., Tan, K.M., Tan, J., Yeong, J.P.S., Lim, T.K.H., Hwang, J.S.G., Ng, Q.S., Soong, Y.L., Ang, M-K., Tan, S.H., Chua, M.L.K., Lim, D.W-T.

Volltext

924P Claudin-1 (CLDN1) tight junction protein expression delineates distinct immune infiltrates in ascending (A) vs descending (D) subtypes of nasopharyngeal carcinoma: Potential i... von Lim, D.W-T., Yeo, E., Neo, J., Ong, E., Chow, W.M., Tan, K.M., Tan, J., Yeong, J.P.S., Lim, T.K.H., Hwang, J.S.G., Ng, Q.S., Soong, Y.L., Ang, M-K., Tan, S.H., Chua, M.L.K.

Volltext

226P LongiBloodImmunoM: A multi-step analysis pipeline for longitudinal blood-based immunomonitoring for immunotherapy clinical trial von Ye, J., Lim, X., Ng, K.S., Kaya, N.A., Lau, M.C., Jia, M., Cheung, C.C.L., Toh, H.C., Choo, S.P., Lee, S.Y., Lee, J.J.X., Liu, J., Lim, T.K.H., Zhai, W., Tai, D.W.M., Yeong, J.P.S.

Volltext

126P Clonal architecture and genomic features of smoking versus non-smoking oncogene-driven East-Asian non-small cell lung cancer von Huang, C-Y., Jiang, N., Shen, M., Lai, G., Takano, A., Lim, T.K.H., Tam, W.L., Skanderup, A., Tan, D.S.W., Rozen, S.G.

Volltext

192P ddPCR versus plasma NGS in detecting clearance of plasma EGFR mutations von Saw, P.L.S., Tan, G.S., Tan, A., Lai, G., Tan, W.C., Tan, E.H., Ang, M-K., Lim, D.W-T., Kanesvaran, R., Ng, Q.S., Jain, A., Tan, W.L., Rajasekaran, T., Chan, J., Teh, Y.L., Tan, S.H., Lim, T.K.H., Tan, D.S.W.

Volltext

267O Distinct phenotypes of locoregionally advanced (LA-NPC) harbor disparate survival outcomes and are associated with germline variants von Ong, E., Sim, A.Y.L., Huang, L., Low, K.P., Yee, W. Wai, Susanti, D., Wang, H., Tan, T.W.K., Fong, K.W., Soong, Y.L., Tan, G.S., Lim, T.K.H., Wee, J.T.S., Lim, D.W.T., Iyer, N.G., Hwang, J.S.G., Abazeed, M., Bei, J.X., Chua, M.L.K.

Volltext

99P Development of a qRT-PCR-based diagnostic test to identify colorectal cancer patients with recurrent R-Spondin gene fusions von Diermayr, V., Sarma, S., Lee, K.F.Y., Ng, P., Tong, C.K., Soon, V., Gan, B.H., Qu, Z.J., Tan, Z., Han, X., Phua, L.Y., Poh, H.M., Gan, A., Camat, D.M., Weng, R., Cheong, E.W., Inoue, M., Lezhava, A., Tan, I.B., Lim, T.K.H.

Volltext

PO-1034: Chemoradiation-induced intratumoral immune microenvironment changes in oesophageal cancer von Yip, C., Yeong, J.P.S., Leow, W.Q., Wang, L.M., Lee, L.A.L., Lim, T.K.H., Siow, T.R., Lim, F.W.T., Wang, M.L.C., Ho, S.Z., Wang, F., Ng, M.C.H., Ong, S.J., Lam, J.Y.C., Wong, W.K., Ong, H.S., Lim, E., Eng, A.K.H., Lim, C.H., Chan, W.H., Wong, A.S.Y., Lee, J., Lin, J., Ong, E., Chua, M.L.K.

Volltext

385 - The heterogeneity of circulating lung tumor cells from non-small cell lung cancer patients von Kong, S.L., Tan, S.J., Lim, T.K.H., Poh, H.M., Yeo, T.Z.X., Liu, X., Chua, Y.W., Bhagat, A.A., Lim, W.T., Hillmer, A.M.

Volltext

Phase I study: Safety and tolerability of varlitinib (VAR) in combination with oxaliplatin and capecitabine (COX) or oxaliplatin and 5-FU (FOL) in advanced solid tumours von Seet, A, Choo, S P, Tai, D W M, Lam, Y C J, Teng, W T, Lim, C, Lim, T K H, Tan, I B, Petricoin, E, Ng, M

Volltext

230P Clinicopathologic and molecular features of STK11-mutated NSCLC von Saw, P.L.S., Pang, M., Tan, G.S., Sim, N.L., Patteri, C., Lai, G., Tan, A., Chan, J., Tan, W.L., Ng, Q.S., Ang, M-K., Lim, D.W-T., Lim, T.K.H., Skanderup, A., Tan, D.S.W.

Volltext

Somatostatin receptor 2 expression and clinical significance in pulmonary lymphoepithelioma-like carcinoma von Han, S., Yeong, J., Lim, C.X., Ang, M.-K., Lim, W.T.D., Toh, C.K., Ng, Q.S., Tan, D.S., Lim, T.K.H., Loh, J.H., Tanako, A., Kanesvaran, R., Tan, W.L., Rajasekaran, T., Nei, W., Jain, A.

Volltext

118 - Evolutionary trajectory of Asian EGFR mutation positive lung adenocarcinomas leads to “high intratumor heterogeneity” von Nahar, R., Zhai, W., Zhang, T., Takano, A., Khng, A.J., Lee, Y.Y., Liu, X., Lim, C.H., Lim, T.K.H., Koh, T.P.T., Aung, Z.W., Teo, A.S.M., Chan, C.X., Toh, C.K., Lim, W.T., Lim, B., Tam, W.L., Tan, E.H., Tan, D.S.W., Hillmer, A.M.

Volltext

P3.01-017 Clinical Outcomes of Patients with EGFR T790M + NSCLC on Osimertinib von Tan, W.L., Hennedige, T.P., Ng, Q.S., Tan, S.H., Tran, N.T.A., Chua, B.J.G., Toh, C.K., Tan, E.H., Tan, D., Ang, M., Kanesvaran, R., Jain, A., Lim, T.K.H., Gogna, A., Koh, M., Yip, C.S.P., Thng, C.H., Chowbay, B., Tan, M.H., Lim, W.

Volltext